Upregulation of miR‑126 inhibits podocyte injury in sepsis via EGFL6/DKC1 signaling pathway

Su,Jianming; Ding,Limin

doi:10.3892/mmr.2021.12012

Upregulation of miR‑126 inhibits podocyte injury in sepsis via EGFL6/DKC1 signaling pathway

Authors:
- Jianming Su
- Limin Ding
View Affiliations

Affiliations: Department of Emergency, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310006, P.R. China
Published online on: March 16, 2021 https://doi.org/10.3892/mmr.2021.12012
Article Number: 373

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Sepsis‑induced cardiorenal syndrome is one of the multiple organ dysfunctions observed in sepsis. It is determined by a primary dysfunction in one organ that leads to secondary injury to another organ. Studies have shown the involvement of microRNAs (miRs) in the diagnosis and prognosis of several pathologies. However, the implication of miR‑126 in the podocyte damage associated with sepsis has not been evaluated until now. In the current study, the miR‑126 expression was downregulated in a podocyte injury model together with downregulation of nephrin expression. The transfection of podocytes from podocyte injury group with miR‑126 mimics demonstrated an increase in cell proliferation and a decrease in cell apoptosis. Bioinformatics analysis predicted that the target of miR‑126 was epidermal growth factor‑like domain multiple 6 (EGFL6) and dyskeratosis congenita 1 (DKC1) and these were confirmed by dual‑luciferase reporter assay. miR‑126 upregulation determined EGFL6 and DKC1 upregulation and prevented podocyte injury. The current study demonstrated that overexpression of miR‑126 could protect podocytes from sepsis‑induced injury through an EGFL6/DKC1 signaling pathway.

View Figures

View References

1	Zlatian O, Balasoiu AT, Balasoiu M, Cristea O, Docea AO, Mitrut R, Spandidos DA, Tsatsakis AM, Bancescu G and Calina D: Antimicrobial resistance in bacterial pathogens among hospitalised patients with severe invasive infections. Exp Ther Med. 16:4499–4510. 2018.PubMed/NCBI
2	Călina D, Docea AO, Rosu L, Zlatian O, Rosu AF, Anghelina F, Rogoveanu O, Arsene AL, Nicolae AC, Drăgoi CM, et al: Antimicrobial resistance development following surgical site infections. Mol Med Rep. 15:681–688. 2017. View Article : Google Scholar : PubMed/NCBI
3	Ungureanu A, Zlatian O, Mitroi G, Drocaş A, Ţîrcă T, Călina D, Dehelean C, Docea AO, Izotov BN, Rakitskii VN, et al: Staphylococcus aureus colonisation in patients from a primary regional hospital. Mol Med Rep. 16:8771–8780. 2017. View Article : Google Scholar : PubMed/NCBI
4	Calina D, Rosu L, Rosu AF, Ianosi G, Ianosi S, Zlatian O, Mitrut R, Oana DA, Rogoveanu O, Mitruţ P, et al: Etiological diagnosis and pharmacotherapeutic management of parapneumonic pleurisy. Farmacia. 64:946–952. 2016.
5	Tanase A, Colita A, Ianosi G, Neagoe D, Branisteanu DE, Calina D, Docea AO, Tsatsakis A and Ianosi SL: Rare case of disseminated fusariosis in a young patient with graft vs. host disease following an allogeneic transplant. Exp Ther Med. 12:2078–2082. 2016. View Article : Google Scholar : PubMed/NCBI
6	Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, Rubenfeld G, Kahn JM, Shankar-Hari M, Singer M, et al: Assessment of clinical criteria for sepsis: For the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 315:762–774. 2016. View Article : Google Scholar : PubMed/NCBI
7	Marik PE: Patterns of death in patients with sepsis and the use of hydrocortisone, ascorbic acid, and thiamine to prevent these deaths. Surg Infect (Larchmt). 19:812–820. 2018. View Article : Google Scholar : PubMed/NCBI
8	Genga KR and Russell JA: Update of sepsis in the intensive care unit. J Innate Immun. 9:441–455. 2017. View Article : Google Scholar : PubMed/NCBI
9	Shi B, Shi F, Xu K, Shi L, Tang H, Wang N, Wu Y, Gu J, Ding J and Huang Y: The prognostic performance of Sepsis-3 and SIRS criteria for patients with urolithiasis-associated sepsis transferred to ICU following surgical interventions. Exp Ther Med. 18:4165–4172. 2019.PubMed/NCBI
10	Ronco C, Bellasi A and Di Lullo L: Cardiorenal syndrome: An overview. Adv Chronic Kidney Dis. 25:382–390. 2018. View Article : Google Scholar : PubMed/NCBI
11	Greka A and Mundel P: Cell biology and pathology of podocytes. Annu Rev Physiol. 74:299–323. 2012. View Article : Google Scholar : PubMed/NCBI
12	Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Holzman LB, et al: Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol. 16:2941–2952. 2005. View Article : Google Scholar : PubMed/NCBI
13	Gambari R, Brognara E, Spandidos DA and Fabbri E: Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review). Int J Oncol. 49:5–32. 2016. View Article : Google Scholar : PubMed/NCBI
14	Roberts JT and Borchert GM: Computational prediction of MicroRNA target genes, target prediction databases, and web resources. Methods Mol Biol. 1617:109–122. 2017. View Article : Google Scholar : PubMed/NCBI
15	Candido S, Lupo G, Pennisi M, Basile MS, Anfuso CD, Petralia MC, Gattuso G, Vivarelli S, Spandidos DA, Libra M, et al: The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease. Oncol Rep. 42:911–922. 2019.PubMed/NCBI
16	Bibaki E, Tsitoura E, Vasarmidi E, Margaritopoulos G, Trachalaki A, Koutoulaki C, Georgopoulou T, Spandidos DA, Tzanakis N and Antoniou KM: miR-185 and miR-29a are similarly expressed in the bronchoalveolar lavage cells in IPF and lung cancer but common targets DNMT1 and COL1A1 show disease specific patterns. Mol Med Rep. 17:7105–7112. 2018.PubMed/NCBI
17	Falzone L, Romano GL, Salemi R, Bucolo C, Tomasello B, Lupo G, Anfuso CD, Spandidos DA, Libra M and Candido S: Prognostic significance of deregulated microRNAs in uveal melanomas. Mol Med Rep. 19:2599–2610. 2019.PubMed/NCBI
18	Doukas SG, Vageli DP, Lazopoulos G, Spandidos DA, Sasaki CT and Tsatsakis A: The effect of NNK, a tobacco smoke carcinogen, on the miRNA and mismatch DNA repair expression profiles in lung and head and neck squamous cancer cells. Cells. 9:10312020. View Article : Google Scholar
19	Koutsaki M, Libra M, Spandidos DA and Zaravinos A: The miR-200 family in ovarian cancer. Oncotarget. 8:66629–66640. 2017. View Article : Google Scholar : PubMed/NCBI
20	Sahu SC and Tsatsakis A: microRNAs: Potential biomarkers of toxicity: A special issue of the Journal Toxicology Reports. Toxicol Rep. 7:198–199. 2020. View Article : Google Scholar : PubMed/NCBI
21	Falzone L, Grimaldi M, Celentano E, Augustin LSA and Libra M: Identification of modulated MicroRNAs associated with breast cancer, diet, and physical activity. Cancers (Basel). 12:25552020. View Article : Google Scholar
22	Polo A, Crispo A, Cerino P, Falzone L, Candido S, Giudice A, De Petro G, Ciliberto G, Montella M, Budillon A, et al: Environment and bladder cancer: Molecular analysis by interaction networks. Oncotarget. 8:65240–65252. 2017. View Article : Google Scholar : PubMed/NCBI
23	Filetti V, Falzone L, Rapisarda V, Caltabiano R, Eleonora Graziano AC, Ledda C and Loreto C: Modulation of microRNA expression levels after naturally occurring asbestiform fibers exposure as a diagnostic biomarker of mesothelial neoplastic transformation. Ecotoxicol Environ Saf. 198:1106402020. View Article : Google Scholar : PubMed/NCBI
24	Sharifi-Rad J, Rodrigues CF, Sharopov F, Docea AO, Can Karaca A, Sharifi-Rad M, Kahveci Karıncaoglu D, Gülseren G, Şenol E, Demircan E, et al: Diet, lifestyle and cardiovascular diseases: Linking pathophysiology to cardioprotective effects of natural bioactive compounds. Int J Environ Res Public Health. 17:23262020. View Article : Google Scholar
25	Sharifi-Rad M, Anil Kumar NV, Zucca P, Varoni EM, Dini L, Panzarini E, Rajkovic J, Tsouh Fokou PV, Azzini E, Peluso I, et al: Lifestyle, oxidative stress, and antioxidants: Back and forth in the pathophysiology of chronic diseases. Front Physiol. 11:6942020. View Article : Google Scholar : PubMed/NCBI
26	Finotti A, Allegretti M, Gasparello J, Giacomini P, Spandidos DA, Spoto G and Gambari R: Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review). Int J Oncol. 53:1395–1434. 2018.PubMed/NCBI
27	Silantyev AS, Falzone L, Libra M, Gurina OI, Kardashova KS, Nikolouzakis TK, Nosyrev AE, Sutton CW, Mitsias PD and Tsatsakis A: Current and future trends on diagnosis and prognosis of glioblastoma: From molecular biology to proteomics. Cells. 8:8632019. View Article : Google Scholar
28	Nikolouzakis TK, Vassilopoulou L, Fragkiadaki P, Mariolis Sapsakos T, Papadakis GZ, Spandidos DA, Tsatsakis AM and Tsiaoussis J: Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review). Oncol Rep. 39:2455–2472. 2018.PubMed/NCBI
29	Zaravinos A, Radojicic J, Lambrou GI, Volanis D, Delakas D, Stathopoulos EN and Spandidos DA: Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer. J Urol. 188:615–623. 2012. View Article : Google Scholar : PubMed/NCBI
30	Rizos E, Siafakas N, Skourti E, Papageorgiou C, Tsoporis J, Parker TH, Christodoulou DI, Spandidos DA, Katsantoni E and Zoumpourlis V: miRNAs and their role in the correlation between schizophrenia and cancer (Review). Mol Med Rep. 14:4942–4946. 2016. View Article : Google Scholar : PubMed/NCBI
31	Doukas SG, Vageli DP, Nikolouzakis TK, Falzone L, Docea AO, Lazopoulos G, Kalbakis K and Tsatsakis A: Role of DNA mismatch repair genes in lung and head and neck cancer (Review). World Acad Sci J. 1:184–191. 2019.
32	Cheng Y, Yang M and Peng J: Correlation the between the regulation of miRNA-1 in c-Met-induced EMT and cervical cancer progression. Oncol Lett. 17:3341–3349. 2019.PubMed/NCBI
33	Xiong DD, Xu WQ, He RQ, Dang YW, Chen G and Luo DZ: In silico analysis identified miRNA based therapeutic agents against glioblastoma multiforme. Oncol Rep. 41:2194–2208. 2019.PubMed/NCBI
34	Liu C, Tong Z, Tan J, Xin Z, Wang Z and Tian L: MicroRNA-21-5p targeting PDCD4 suppresses apoptosis via regulating the PI3K/AKT/FOXO1 signaling pathway in tongue squamous cell carcinoma. Exp Ther Med. 18:3543–3551. 2019.PubMed/NCBI
35	Krill KT, Gurdziel K, Heaton JH, Simon DP and Hammer GD: Dicer deficiency reveals microRNAs predicted to control gene expression in the developing adrenal cortex. Mol Endocrinol. 27:754–768. 2013. View Article : Google Scholar : PubMed/NCBI
36	Asgeirsdóttir SA, van Solingen C, Kurniati NF, Zwiers PJ, Heeringa P, van Meurs M, Satchell SC, Saleem MA, Mathieson PW, Banas B, et al: MicroRNA-126 contributes to renal microvascular heterogeneity of VCAM-1 protein expression in acute inflammation. Am J Physiol Renal Physiol. 302:F1630–F1639. 2012. View Article : Google Scholar : PubMed/NCBI
37	Metzinger-Le Meuth V, Andrianome S, Chillon JM, Bengrine A, Massy ZA and Metzinger L: microRNAs are dysregulated in the cerebral microvasculature of CKD mice. Front Biosci (Elite Ed). 6:80–88. 2014. View Article : Google Scholar : PubMed/NCBI
38	Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E, et al: Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 107:810–817. 2010. View Article : Google Scholar : PubMed/NCBI
39	Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R and Olson EN: The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 15:261–271. 2008. View Article : Google Scholar : PubMed/NCBI
40	Liu Y, Gao G, Yang C, Zhou K, Shen B, Liang H and Jiang X: Stability of miR-126 in Urine and Its Potential as a Biomarker for Renal Endothelial Injury with Diabetic Nephropathy. Int J Endocrinol. 2014:3931092014. View Article : Google Scholar : PubMed/NCBI
41	Sheng X, Zuo X, Liu X, Zhou Y and Sun X: Crosstalk between TLR4 and Notch1 signaling in the IgA nephropathy during inflammatory response. Int Urol Nephrol. 50:779–785. 2018. View Article : Google Scholar : PubMed/NCBI
42	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
43	Langham RG, Kelly DJ, Cox AJ, Thomson NM, Holthöfer H, Zaoui P, Pinel N, Cordonnier DJ and Gilbert RE: Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: Effects of angiotensin converting enzyme inhibition. Diabetologia. 45:1572–1576. 2002. View Article : Google Scholar : PubMed/NCBI
44	Wolenski FS, Shah P, Sano T, Shinozawa T, Bernard H, Gallacher MJ, Wyllie SD, Varrone G, Cicia LA, Carsillo ME, et al: Identification of microRNA biomarker candidates in urine and plasma from rats with kidney or liver damage. J Appl Toxicol. 37:278–286. 2017. View Article : Google Scholar : PubMed/NCBI
45	Zhou Z, Wan J, Hou X, Geng J, Li X and Bai X: MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy. Cell Death Dis. 8:e26582017. View Article : Google Scholar : PubMed/NCBI
46	Chen X, Zhao L, Xing Y and Lin B: Down-regulation of microRNA-21 reduces inflammation and podocyte apoptosis in diabetic nephropathy by relieving the repression of TIMP3 expression. Biomed Pharmacother. 108:7–14. 2018. View Article : Google Scholar : PubMed/NCBI
47	Fu Y, Wang C, Zhang D, Chu X, Zhang Y and Li J: miR-15b-5p ameliorated high glucose-induced podocyte injury through repressing apoptosis, oxidative stress, and inflammatory responses by targeting Sema3A. J Cell Physiol. 234:20869–20878. 2019. View Article : Google Scholar : PubMed/NCBI
48	Xian Y, Dong L, Jia Y, Lin Y, Jiao W and Wang Y: miR-370 promotes high glucose-induced podocyte injuries by inhibiting angiotensin II type 1 receptor-associated protein. Cell Biol Int. 42:1545–1555. 2018. View Article : Google Scholar : PubMed/NCBI
49	Liu XD, Zhang LY, Zhu TC, Zhang RF, Wang SL and Bao Y: Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways. Int J Clin Exp Pathol. 8:4525–4534. 2015.PubMed/NCBI
50	Liu D, Liu F, Wang X, Qiao Y, Pan S, Yang Y, Hu Y, Zhang Y, Tian F and Liu Z: MiR-130a-5p prevents angiotensin II-induced podocyte apoptosis by modulating M-type phospholipase A2 receptor. Cell Cycle. 17:2484–2495. 2018. View Article : Google Scholar : PubMed/NCBI
51	Henique C, Bollée G, Loyer X, Grahammer F, Dhaun N, Camus M, Vernerey J, Guyonnet L, Gaillard F, Lazareth H, et al: Genetic and pharmacological inhibition of microRNA-92a maintains podocyte cell cycle quiescence and limits crescentic glomerulonephritis. Nat Commun. 8:18292017. View Article : Google Scholar : PubMed/NCBI
52	Xu G, Mo L, Wu C, Shen X, Dong H, Yu L, Pan P and Pan K: The miR-15a-5p-XIST-CUL3 regulatory axis is important for sepsis-induced acute kidney injury. Ren Fail. 41:955–966. 2019. View Article : Google Scholar : PubMed/NCBI
53	Zheng Z, Hu H, Tong Y, Hu Z, Cao S, Shan C, Lin W, Yin Y and Li Z: MiR-27b regulates podocyte survival through targeting adenosine receptor 2B in podocytes from non-human primate. Cell Death Dis. 9:11332018. View Article : Google Scholar : PubMed/NCBI
54	Noh K, Mangala LS, Han H-D, Zhang N, Pradeep S, Wu SY, Ma S, Mora E, Rupaimoole R, Jiang D, et al: Differential effects of EGFL6 on tumor versus wound angiogenesis. Cell Rep. 21:2785–2795. 2017. View Article : Google Scholar : PubMed/NCBI
55	Larimer BM and Deutscher SL: Identification of a peptide from in vivo bacteriophage display with homology to EGFL6: A candidate tumor vasculature ligand in breast cancer. J Mol Biomark Diagn. 5:1782014.PubMed/NCBI
56	Mas VR, Maluf DG, Archer KJ, Yanek KC and Fisher RA: Angiogenesis soluble factors as hepatocellular carcinoma noninvasive markers for monitoring hepatitis C virus cirrhotic patients awaiting liver transplantation. Transplantation. 84:1262–1271. 2007. View Article : Google Scholar : PubMed/NCBI
57	Ballew BJ and Savage SA: Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol. 6:327–337. 2013. View Article : Google Scholar : PubMed/NCBI
58	Cao DW, Jiang CM, Wan C, Zhang M, Zhang QY, Zhao M, Yang B, Zhu DL and Han X: Upregulation of miR-126 delays the senescence of human glomerular mesangial cells Induced by high glucose via telomere-p53-p21-Rb signaling pathway. Curr Med Sci. 38:758–764. 2018. View Article : Google Scholar : PubMed/NCBI
59	Yu X, Odenthal M and Fries JW: Exosomes as miRNA carriers: Formation-function-future. Int J Mol Sci. 17:20282016. View Article : Google Scholar